Antisense oligonucleotide therapy for TTR amyloidosis

被引：0
|
作者：
Benson, M. D. [1 ,2 ]
Pandey, S. [3 ]
Witchell, D. [3 ]
Jazayeri, A. [3 ]
Siwkowski, A. [3 ]
Monia, B. [3 ]
Kluve-Beckerman, B. [1 ]
机构：
[1] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA
[2] Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA
[3] ISIS Pharmaceut, Carlsbad, CA 92008 USA
来源：
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | 2010年 / 17卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：53 / 53
页数：1
相关论文
共 50 条
  • [1] Antisense oligonucleotide therapy for TTR amyloidosis
    Benson, M. D.
    Pandey, S.
    Witchell, D.
    Jazayeri, A.
    Siwkowski, A.
    Monia, B.
    Kluve-Beckerman, B.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2011, 18 : 60 - 60
  • [2] TREATMENT OF TRANSTHYRETIN AMYLOIDOSIS (ATTR) WITH A TTR-SPECIFIC SECOND GENERATION ANTISENSE OLIGONUCLEOTIDE (ASO)
    Benson, M. D.
    Kincaid, J. C.
    Ackermann, E.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2015, 20 (02) : 104 - 105
  • [3] POTENTIAL REVERSAL OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY WITH TTR SPECIFIC ANTISENSE OLIGONUCLEOTIDE THERAPY
    Dasgupta, Noel Rakhi
    Benson, Merrill D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 660 - 660
  • [4] Treatment of transthyretin (TTR) amyloid cardiomyopathy with an antisense oligonucleotide inhibitor of TTR synthesis
    Merrill D Benson
    Elizabeth J Ackermann
    Brett P Monia
    Orphanet Journal of Rare Diseases, 10 (Suppl 1)
  • [5] Treatment of ATTR cardiomyopathy with a TTR specific antisense oligonucleotide, inotersen
    Dasgupta, Noel R.
    Benson, Merrill D.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2019, 26 : 20 - 21
  • [6] TRANSTHYRETIN AMYLOID CARDIOMYOPATHY TREATMENT WITH AN ANTISENSE OLIGONUCLEOTIDE INHIBITOR OF TTR (ISIS-TTR RX)
    Benson, M. D.
    Ackermann, E. J.
    Monia, B.
    CARDIOLOGY, 2015, 131 : 233 - 233
  • [7] Antisense Oligonucleotide Therapy for Calmodulinopathy
    Bortolin, Raul H.
    Nawar, Farina
    Park, Chaehyoung
    Trembley, Michael A.
    Prondzynski, Maksymilian
    Sweat, Mason E.
    Wang, Peizhe
    Chen, Jiehui
    Lu, Fujian
    Liou, Carter
    Berkson, Paul
    Keating, Erin M.
    Yoshinaga, Daisuke
    Pavlaki, Nikoleta
    Samenuk, Thomas
    Cavazzoni, Cecilia B.
    Sage, Peter T.
    Ma, Qing
    Whitehill, Robert D.
    Abrams, Dominic J.
    Carreon, Chrystalle Katte
    Putra, Juan
    Alexandrescu, Sanda
    Guo, Shuai
    Tsai, Wen-Chin
    Rubart, Michael
    Kubli, Dieter A.
    Mullick, Adam E.
    Bezzerides, Vassilios J.
    Pu, William T.
    CIRCULATION, 2024, 150 (15) : 1199 - 1210
  • [8] Antisense oligonucleotide therapy in cancer
    Stephens, AC
    Rivers, RPA
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2003, 5 (02) : 118 - 122
  • [9] Antisense oligonucleotide therapy for HCMV
    Manoharan, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 21 - CARB
  • [10] Antisense oligonucleotide therapy in urology
    Kausch, I
    Böhle, A
    JOURNAL OF UROLOGY, 2002, 168 (01): : 239 - 247
12345